|

Nucleotide analogs Clinical Trials

1 actively recruiting trial

Also known as: Entecavir, Tenofovir alafenamide fumarate, Tenofovir disoproxil fumarate

Pipeline

Phase 4: 1

Top Sponsors

  • The Second Affiliated Hospital of Chongqing Medical University1

Indications

Other1 trial

ASC22 Combined With Peg-IFNa in Achieving Functional Cure in Patients With Chronic Hepatitis B Virus Infection
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.